Infinity Pharmaceuticals reported $72.58M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Amgen AMGN:US $ 59196M 1969M
AstraZeneca AZN:LN 100273M 5090M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Cytori Therapeutics CYTX:US $ 24.52M 2.54M
Eisai 4523:JP Y 1239315M 71959M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Genocea Biosciences GNCA:US $ 38.79M 17.18M
Gilead Sciences GILD:US $ 63080M 4872M
GlaxoSmithKline GSK:LN 89689M 10586M
Infinity Pharmaceuticals INFI:US $ 72.58M 12.21M
Johnson & Johnson JNJ:US $ 178355M 3663M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Novartis NOVN:VX SF 125218M 6577M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Tg Therapeutics TGTX:US $ 303.03M 76.6M
Vascular Biogenics VBLT:US 56.29M 8.37M
YTE INCY:US $ 5054.22M 120.87M